mRNA |
GMX-1778 |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.01 |
mRNA |
ibrutinib |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.01 |
mRNA |
tipifarnib |
CTRPv2 |
pan-cancer |
AAC |
-0.079 |
0.02 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.075 |
0.02 |
mRNA |
CIL56 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.02 |
mRNA |
ML210 |
CTRPv2 |
pan-cancer |
AAC |
0.083 |
0.02 |
mRNA |
BRD-M00053801 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.02 |
mRNA |
Topotecan |
CTRPv2 |
pan-cancer |
AAC |
-0.08 |
0.02 |
mRNA |
HBX-41108 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.02 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.081 |
0.02 |